Ghent University Academic Bibliography

Your filters: cql: author="Dirix, Luc" or (type any "bookEditor issueEditor" and editor="Dirix, Luc")

Add to list
- Journal Article
- A1
- open access
Autogene cevumeran with or without atezolizumab in advanced solid tumors : a phase 1 trial

Juanita Lopez, Thomas Powles, Fadi Braiteh, Lillian L. Siu, Patricia LoRusso, Claire F. Friedman, Ani S. Balmanoukian, Michael Gordon, Jeffrey Yachnin, Sylvie Rottey (UGent) , et al.

(2025) NATURE MEDICINE. 31(1). p.152-164
Add to list
Challenges in neoantigen-directed therapeutics

Lien Lybaert, Steve Lefever (UGent) , Bruno Fant, Evelien Smits, Bruno De Geest (UGent) , Karine Breckpot, Luc Dirix, Steven A. Feldman, Wim Van Criekinge (UGent) , Kris Thielemans, et al.

(2023) CANCER CELL. 41(1). p.15-40
Add to list
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer : a study of the Belgian and Luxembourg Gynaecological Oncology Group

Ignace Vergote, Els Van Nieuwenhuysen, Stefanie De Waele, Christof Vulsteke, Caroline Lamot, Heidi Van den Bulck, Nele Claes, Marie-Pascale Graas, Guy Debrock, Isabelle Spoormans, et al.

(2022) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 32(6). p.753-760
Add to list
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD) : a multicentre, open-label, phase 2 trial

Matthew R Smith, Howard I Scher, Shahneen Sandhu, Eleni Efstathiou, Primo N Lara, Evan Y Yu, Daniel J George, Kim N Chi, Fred Saad, Olof Ståhl, et al.

(2022) LANCET ONCOLOGY. 23(3). p.362-373
Add to list
Can medical imaging identify the histopathological growth patterns of liver metastases?

Emily Latacz, Pieter-Jan van Dam, Christian Vanhove (UGent) , Laura Llado, Benedicte Descamps (UGent) , Núria Ruiz, Ines Joye, Dirk Grünhagen, Steven Van Laere, Piet Dirix, et al.

(2021) SEMINARS IN CANCER BIOLOGY. 71. p.33-41
Add to list
Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy

Piet Dirix, Michiel Strijbos, Tom Van den Mooter, Nick Liefhooghe, Siska Van Bruwaene, Pieter Uvin, Christophe Ghysel, Dieter Ost, Peter Schatteman, Samuel Bral, et al.

(2020) FUTURE ONCOLOGY. 16(16). p.1083-1089
Add to list
- Conference Paper
- C3
A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors

Juanita S. Lopez, Ross Camidge, Marco Iafolla, Sylvie Rottey (UGent) , Martin Schuler, Matthew Hellmann, Ani Balmanoukian, Luc Dirix, Michael Gordon, Ryan Sullivan, et al.

(2020) CANCER RESEARCH. 80(16).
Add to list
- Journal Article
- A1
- open access
Pan-cancer analysis of whole genomes

Peter J. Campbell, Gad Getz, Jan O. Korbel, Joshua M. Stuart, Jennifer L. Jennings, Lincoln D. Stein, Marc D. Perry, Hardeep K. Nahal-Bose, B. F. Francis Ouellette, Constance H. Li, et al.

(2020) NATURE. 578(7793). p.82-93
Add to list
- Journal Article
- A1
- open access
Comparative profiling of metastatic 4T1- vs. non-metastatic Py230-based mammary tumors in an intraductal model for triple-negative breast cancer

Jonas Steenbrugge (UGent) , Niels Vander Elst, Kristel Demeyere (UGent) , Olivier De Wever (UGent) , Niek Sanders (UGent) , Wim Van Den Broeck (UGent) , Luc Dirix, Steven Van Laere and Evelyne Meyer (UGent)

(2019) FRONTIERS IN IMMUNOLOGY. 10.
Add to list
- Journal Article
- A1
- open access
A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)

Jean-Pascal Machiels, Ramon Salazar, Sylvie Rottey (UGent) , Ignacio Duran, Luc Dirix, Karen Geboes (UGent) , Christine Wilkinson-Blanc, Gillian Pover, Simon Alvis, Brian Champion, et al.

(2019) JOURNAL FOR IMMUNOTHERAPY OF CANCER. 7.

Academic Bibliography

Autogene cevumeran with or without atezolizumab in advanced solid tumors : a phase 1 trial

Challenges in neoantigen-directed therapeutics

Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer : a study of the Belgian and Luxembourg Gynaecological Oncology Group

Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD) : a multicentre, open-label, phase 2 trial

Can medical imaging identify the histopathological growth patterns of liver metastases?

Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy

A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors

Pan-cancer analysis of whole genomes

Comparative profiling of metastatic 4T1- vs. non-metastatic Py230-based mammary tumors in an intraductal model for triple-negative breast cancer

A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)

Contents

Support

Contact